128 related articles for article (PubMed ID: 9530526)
1. Phase III interlaboratory study of FETAX, Part 2: interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay--Xenopus (FETAX).
Fort DJ; Stover EL; Bantle JA; Rayburn JR; Hull MA; Finch RA; Burton DT; Turley SD; Dawson DA; Linder G; Buchwalter D; Dumont JN; Kumsher-King M; Gaudet-Hull AM
Drug Chem Toxicol; 1998 Feb; 21(1):1-14. PubMed ID: 9530526
[TBL] [Abstract][Full Text] [Related]
2. Phase III interlaboratory study of FETAX. Part 3. FETAX validation using 12 compounds with and without an exogenous metabolic activation system.
Bantle JA; Finch RA; Fort DJ; Stover EL; Hull M; Kumsher-King M; Gaudet-Hull AM
J Appl Toxicol; 1999; 19(6):447-72. PubMed ID: 10547627
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the developmental toxicity of caffeine and caffeine metabolites using the frog embryo teratogenesis assay--Xenopus (FETAX).
Fort DJ; Stover EL; Propst TL; Faulkner BC; Vollmuth TA; Murray FJ
Food Chem Toxicol; 1998 Jul; 36(7):591-600. PubMed ID: 9687966
[TBL] [Abstract][Full Text] [Related]
4. Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixtures.
Fort DJ; Rogers RL; Stover EL; Finch RA
Drug Chem Toxicol; 2001 May; 24(2):103-15. PubMed ID: 11360429
[TBL] [Abstract][Full Text] [Related]
5. Development of a metabolic activation system for the frog embryo teratogenesis assay: Xenopus (FETAX).
Fort DJ; Dawson DA; Bantle JA
Teratog Carcinog Mutagen; 1988; 8(5):251-63. PubMed ID: 2905834
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the developmental toxicity of five compounds with the frog embryo teratogenesis assay: Xenopus (FETAX) and a metabolic activation system.
Fort DJ; James BL; Bantle JA
J Appl Toxicol; 1989 Dec; 9(6):377-88. PubMed ID: 2613998
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the mechanism of isoniazid-induced developmental toxicity with frog embryo teratogenesis assay: Xenopus (FETAX).
Fort DJ; Bantle JA
Teratog Carcinog Mutagen; 1990; 10(6):463-76. PubMed ID: 1982910
[TBL] [Abstract][Full Text] [Related]
8. Use of Frog Embryo Teratogenesis Assay-Xenopus and an exogenous metabolic activation system to evaluate the developmental toxicity of diphenylhydantoin.
Fort DJ; Bantle JA
Fundam Appl Toxicol; 1990 May; 14(4):720-33. PubMed ID: 2361573
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of acetaminophen-induced developmental toxicity using FETAX.
Fort DJ; Rayburn JR; Bantle JA
Drug Chem Toxicol; 1992; 15(4):329-50. PubMed ID: 1459044
[TBL] [Abstract][Full Text] [Related]
10. Assessing the efficacy of an Aroclor 1254-induced exogenous metabolic activation system for FETAX.
Fort DJ; Rayburn JR; DeYoung DJ; Bantle JA
Drug Chem Toxicol; 1991; 14(1-2):143-60. PubMed ID: 1889373
[TBL] [Abstract][Full Text] [Related]
11. FETAX interlaboratory validation study: phase III--Part 1 testing.
Bantle JA; Finch RA; Burton DT; Fort DJ; Dawson DA; Linder G; Rayburn JR; Hull M; Kumsher-King M; Gaudet-Hull AM; Turley SD
J Appl Toxicol; 1996; 16(6):517-28. PubMed ID: 8956098
[TBL] [Abstract][Full Text] [Related]
12. Teratogenic assessment of four solvents using the Frog Embryo Teratogenesis Assay--Xenopus (FETAX).
Dresser TH; Rivera ER; Hoffmann FJ; Finch RA
J Appl Toxicol; 1992 Feb; 12(1):49-56. PubMed ID: 1564253
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the Teratogenicity of Ritodrine and Nifedipine using a Frog Embryo Teratogenesis assay (FETAX).
Boğa Pekmezekmek A; Binokay US; Seçilmiş MA; Kumcu E; Şimşek E; Akillioğlu K; Sertdemir Y; Özaykan B
Drug Chem Toxicol; 2015; 38(3):254-65. PubMed ID: 25156158
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the developmental toxicities of coumarin, 4-hydroxycoumarin, and 7-hydroxycoumarin using FETAX.
Fort DJ; Stover EL; Propst T; Hull MA; Bantle JA
Drug Chem Toxicol; 1998 Feb; 21(1):15-26. PubMed ID: 9530527
[TBL] [Abstract][Full Text] [Related]
15. Initial interlaboratory validation study of FETAX: phase I testing.
Bantle JA; Burton DT; Dawson DA; Dumont JN; Finch RA; Fort DJ; Linder G; Rayburn JR; Buchwalter D; Maurice MA
J Appl Toxicol; 1994; 14(3):213-23. PubMed ID: 8083483
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Xenopus tropicalis as an alternative test organism for frog embryo teratogenesis assay--Xenopus (FETAX).
Song MO; Fort DJ; McLaughlin DL; Rogers RL; Thomas JH; Buzzard BO; Noll AM; Myers NK
Drug Chem Toxicol; 2003 Aug; 26(3):177-89. PubMed ID: 12953658
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the developmental toxicity of nicotine and cotinine with frog embryo teratogenesis assay: Xenopus.
Dawson DA; Fort DJ; Smith GJ; Newell DL; Bantle JA
Teratog Carcinog Mutagen; 1988; 8(6):329-38. PubMed ID: 2905544
[TBL] [Abstract][Full Text] [Related]
18. Developmental toxicology of potato alkaloids in the frog embryo teratogenesis assay--Xenopus (FETAX).
Friedman M; Rayburn JR; Bantle JA
Food Chem Toxicol; 1991 Aug; 29(8):537-47. PubMed ID: 1894220
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the toxicity and teratogenity of six commercial textile dyes using the frog embryo teratogenesis assay-Xenopus.
Birhanli A; Ozmen M
Drug Chem Toxicol; 2005; 28(1):51-65. PubMed ID: 15720035
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the teratogenicity of the selective ß3-adrenoceptor agonist, CL 316.243 hydrate by employing FETAX (frog embryo teratogenesis assay).
Boga A; Sertdemir Y; Dogan A
Drug Chem Toxicol; 2017 Jan; 40(1):7-12. PubMed ID: 27063898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
